These data suggest that administration of levocarnitine to healthy elderly subjects may result in reduction of total fat mass, and increase of total muscle mass, may be reduce fatigue and serum lipids
If there's insulin resistance, if there are, uh, metabolic comorbidities, like there's already pre-diabetes type two diabetes, fatty liver disease, there's elevated cardiovascular risk that [00:41:00] is not improving despite trying everything, doing everything right, then that's when GLP ones are considered
212,260,261 By interacting with receptors in the hypothalamus, GLP-1 influences satiety and reduces the consumption of food in both animals and humans
Neurochem Res 38, 201207 (2013)